Sentrx Surgical Patents

Patent portfolio assigned to Sentrx Surgical (verified via public assignee records). Salt Lake City hyaluronic-acid medical/surgical company built on University of Utah crosslinked-HA (BioHAnce / CMHA-S) technology; the operating successor is SentrX Animal Care (founded 2006, veterinary ophthalmology/wound care), acquired by Domes Pharma in Aug 2023. 'Sentrx Surgical' is the original/parent naming for the same Salt Lake City HA-technology lineage. Patents confirmed (BioHAnce crosslinked-HA patented; PatSnap/Synapse lists patents); EyeGate licensed the technology for a human ocular product so is both partner and HA competitor. Same-name disambiguation note.